BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28277349)

  • 21. Trends in the management and outcome of HIV-1-infected women and their infants in the NISDI Perinatal and LILAC cohorts, 2002-2009.
    Stoszek SK; Duarte G; Hance LF; Pinto J; Gouvea MI; Cohen RA; Santos B; Teles E; Succi R; Alarcon JO; Read JS;
    Int J Gynaecol Obstet; 2013 Jul; 122(1):37-43. PubMed ID: 23566742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to antiretroviral therapy after a single, peripartum dose of nevirapine.
    Lockman S; Shapiro RL; Smeaton LM; Wester C; Thior I; Stevens L; Chand F; Makhema J; Moffat C; Asmelash A; Ndase P; Arimi P; van Widenfelt E; Mazhani L; Novitsky V; Lagakos S; Essex M
    N Engl J Med; 2007 Jan; 356(2):135-47. PubMed ID: 17215531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for HIV Infection in Pregnant Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Selph SS; Bougatsos C; Dana T; Grusing S; Chou R
    JAMA; 2019 Jun; 321(23):2349-2360. PubMed ID: 31184704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
    Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L;
    AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimated Perinatal HIV Infection Among Infants Born in the United States, 2002-2013.
    Taylor AW; Nesheim SR; Zhang X; Song R; FitzHarris LF; Lampe MA; Weidle PJ; Sweeney P
    JAMA Pediatr; 2017 May; 171(5):435-442. PubMed ID: 28319246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mother-to-child transmission of HIV: experience at a referral hospital in Saudi Arabia.
    Edathodu J; Halim MM; Dahham MB; Alrajhi AA
    Ann Saudi Med; 2010; 30(1):15-7. PubMed ID: 20103953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
    Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S;
    Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe.
    ; Boer K; England K; Godfried MH; Thorne C
    HIV Med; 2010 Jul; 11(6):368-78. PubMed ID: 20059573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.
    Dickover RE; Garratty EM; Herman SA; Sim MS; Plaeger S; Boyer PJ; Keller M; Deveikis A; Stiehm ER; Bryson YJ
    JAMA; 1996 Feb; 275(8):599-605. PubMed ID: 8594240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Follow up of HIV perinatal exposure and accomplishment of strategies to reduce the risk of viral transmission, experience in a reference hospital in Medellín.
    Arango-Ferreira C; Villegas DI; Burbano LD; Quevedo A
    Biomedica; 2019 Aug; 39(Supl. 2):66-77. PubMed ID: 31529835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ongoing Maternal-Child Transmission of HIV in an Urban Area, 2003-2012.
    Rutstein RM; Volkman KM; Bonda S; Shah SS
    Hosp Pediatr; 2015 Feb; 5(2):92-5. PubMed ID: 25646202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal Humoral Immune Responses Do Not Predict Postnatal HIV-1 Transmission Risk in Antiretroviral-Treated Mothers from the IMPAACT PROMISE Study.
    Hompe ED; Jacobson DL; Eudailey JA; Butler K; Edwards W; Pollara J; Brummel SS; Fouda GG; Chinula L; Kamanga M; Kinikar A; Moodley D; Owor M; Fowler MG; Permar SR
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31645430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Missed opportunities to prevent mother-to-child transmission of HIV in Italy.
    Di Biagio A; Taramasso L; Gustinetti G; Burastero G; Giacomet V; La Rovere D; Genovese O; Giaquinto C; Rampon O; Carloni I; Hyppolite TK; Palandri L; Bernardi S; Bruzzese E; Badolato R; Gabiano C; Chiappini E; De Martino M; Galli L;
    HIV Med; 2019 May; 20(5):330-336. PubMed ID: 30924576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Missed Opportunities along the Prevention of Mother-to-Child Transmission Services Cascade in South Africa: Uptake, Determinants, and Attributable Risk (the SAPMTCTE).
    Woldesenbet S; Jackson D; Lombard C; Dinh TH; Puren A; Sherman G; Ramokolo V; Doherty T; Mogashoa M; Bhardwaj S; Chopra M; Shaffer N; Pillay Y; Goga A;
    PLoS One; 2015; 10(7):e0132425. PubMed ID: 26147598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 90-90-90 cascade analysis on reported CLHIV infected by mother-to-child transmission in Guangxi, China: a modeling study.
    Wang G; Lu C; Qin S; Wei W; Lai J; Jiang J; Liang B; Zhou O; Han J; Yang Y; Ye L; Liang H; Ning C
    Sci Rep; 2020 Mar; 10(1):5295. PubMed ID: 32210333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women?
    Jasseron C; Mandelbrot L; Tubiana R; Teglas JP; Faye A; Dollfus C; Le Chenadec J; Rouzioux C; Blanche S; Warszawski J;
    AIDS; 2008 Jul; 22(12):1503-11. PubMed ID: 18614874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.
    Newell ML; Huang S; Fiore S; Thorne C; Mandelbrot L; Sullivan JL; Maupin R; Delke I; Watts DH; Gelber RD; Cunningham CK;
    BMC Infect Dis; 2007 Jun; 7():60. PubMed ID: 17584491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.